Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume

-0.01 (-3.85%)
(As of 10:02 AM ET)

Qualigen Therapeutics Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
Short Interest Ratio / Days to Cover
Last Record Date
March 31, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Qualigen Therapeutics ?

Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

QLGN Short Interest Over Time

QLGN Days to Cover Over Time

QLGN Percentage of Float Shorted Over Time

Qualigen Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202479,900 shares $31,960.00 +588.8%1.7%1.3 $0.40
3/15/202411,600 shares $4,294.32 +11.5%0.3%0.2 $0.37
2/29/202410,400 shares $4,785.04 -63.5%0.2%0.2 $0.46
2/15/202428,500 shares $13,523.25 -3.1%0.6%0.7 $0.47
1/31/202429,400 shares $15,452.64 -14.5%0.6%1.1 $0.53
1/15/202434,400 shares $17,595.60 +63.8%0.8%1.3 $0.51
12/31/202321,000 shares $11,550.00 -32.7%0.5%0.9 $0.55
12/15/202331,200 shares $18,033.60 -8.0%0.7%1.6 $0.58
11/30/202333,900 shares $25,052.10 -15.9%0.7%2.5 $0.74
11/15/202340,300 shares $28,250.30 +0.8%0.9%2.7 $0.70
10/31/202340,000 shares $31,108.00 +5.5%0.9%2.7 $0.78
10/15/202337,900 shares $35,091.61 -14.5%0.9%1.9 $0.93
9/30/202344,300 shares $44,743.00 +23.1%1.0%1.7 $1.01
9/15/202336,000 shares $37,800.00 +77.3%0.8%1.4 $1.05
8/31/202320,300 shares $21,112.00 -9.8%0.5%0.8 $1.04
8/15/202322,500 shares $24,525.00 -37.0%0.5%0.9 $1.09
7/31/202335,700 shares $40,341.00 +28.4%0.8%1.2 $1.13
7/15/202327,800 shares $30,749.58 -12.3%0.6%1.1 $1.11
6/30/202331,700 shares $28,878.70 +26.3%0.7%1.1 $0.91
6/15/202325,100 shares $24,098.51 -38.6%0.6%0.7 $0.96
5/31/202340,900 shares $37,746.61 +7.4%0.9%0.2 $0.92
5/15/202338,100 shares $38,862.00 -39.9%0.9%0.2 $1.02
4/30/202363,400 shares $59,507.24 -5.4%1.5%0.4 $0.94
4/15/202367,000 shares $63,650.00 -19.2%1.8%0.4 $0.95
3/31/202382,900 shares $76,690.79 +48.8%2.2%0.2 $0.93
3/15/202355,700 shares $56,257.00 -31.0%1.5%0.2 $1.01
2/28/202380,700 shares $92,466.06 +41.6%2.1%0.3 $1.15
2/15/202357,000 shares $70,965.00 -17.2%1.5%0.2 $1.25
1/31/202368,800 shares $88,752.00 -61.2%1.8%0.3 $1.29
1/15/2023177,200 shares $237,448.00 +84.8%4.6%0.8 $1.34
12/30/202295,900 shares $123,615.10 No Change2.5%0.5 $1.29
12/15/202295,900 shares $136,178.00 +18.1%2.5%3.7 $1.42
11/30/202281,200 shares $121,597.00 -11.8%2.1%3.1 $1.50
11/15/202292,100 shares $20,308.05 -90.0%N/A4.3 $0.22
10/31/2022916,300 shares $201,586.00 -2.7%N/A4.3 $0.22
10/15/2022941,700 shares $253,128.96 -15.9%N/A4 $0.27
9/30/20221,120,000 shares $299,040.00 +25.5%N/A4.7 $0.27
9/15/2022892,200 shares $291,927.84 -11.7%N/A3.6 $0.33
8/31/20221,010,000 shares $384,406.00 -1.0%N/A4.3 $0.38
8/15/20221,020,000 shares $433,500.00 -8.9%N/A4.5 $0.43
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

QLGN Short Interest - Frequently Asked Questions

What is Qualigen Therapeutics' current short interest?

Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 79,900 shares of QLGN short. 1.74% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest.

What is a good short interest ratio for Qualigen Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QLGN shares currently have a short interest ratio of 1.0. Learn More on Qualigen Therapeutics's short interest ratio.

What is a good short interest percentage for Qualigen Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.74% of Qualigen Therapeutics' floating shares are currently sold short.

Is Qualigen Therapeutics' short interest increasing or decreasing?

Qualigen Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 79,900 shares, an increase of 588.8% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Qualigen Therapeutics' float size?

Qualigen Therapeutics currently has issued a total of 6,310,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 4,600,000 shares.

How does Qualigen Therapeutics' short interest compare to its competitors?

1.74% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Qualigen Therapeutics: Clearmind Medicine Inc. (6.12%), Lucy Scientific Discovery Inc. (2.95%), Bio-Path Holdings, Inc. (8.97%), Galmed Pharmaceuticals Ltd. (1.10%), Salarius Pharmaceuticals, Inc. (6.72%), PainReform Ltd. (1.21%), Notable Labs, Ltd. (0.05%), CNS Pharmaceuticals, Inc. (0.49%), Dermata Therapeutics, Inc. (1.73%), InMed Pharmaceuticals Inc. (0.17%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Qualigen Therapeutics stock?

Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. QLGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Qualigen Therapeutics?

A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further.

How often is Qualigen Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is March, 31 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:QLGN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners